SlideShare a Scribd company logo
Major Histocompatibility Complex
(MHC)
BY: DR SADAF MOEEZ
Major Histocompatibility Complex (MHC)
MHC lecture.pptx
MHC lecture.pptx
MHC lecture.pptx
The process by which T
cells are screened so that
only those capable of
binding to MHC are kept
alive called positive
selection
A T cell recognizes antigen as a
peptide bound by a particular
allelic variant of an MHC
molecule, and will not recognize
the same peptide bound to other
MHC molecules. This behavior of T
cells is called MHC restriction
The outstanding feature of
the MHC molecules is their
extensive polymorphism
At least three properties of MHC
molecules are affected by MHC
polymorphism: the range of
peptides bound; the conformation
of the bound peptide; and the
direct interaction of the MHC
molecule with the T-cell receptor
The interaction between
TCRs and peptide-MHC
complex is significant in
maintaining the immune
system against foreign
antigens
Class I MHC
Structure of Class I Molecule
Class II MHC
Structure of Class II Molecule
MHC lecture.pptx
Difference between MHC I and MHC II
1. Antigen Processing
Before an antigen can be presented, it must first be processed.
Processing transforms proteins into antigenic peptides.
 MHC Class I Molecules
1. Intracellular peptides for MHC class I presentation are made
by proteases and the proteasome in the cytosol.
2. Then transported into the endoplasmic reticulum via TAP
(Transporter associated with Antigen Processing) to be further
processed.
3. They are then assembled together with MHC I molecules and
travel to the cell surface ready for presentation.
Antigen Processing and Presentation
 MCH Class II Molecules
1. The route of processing for exogenous antigens for MHC class
II presentation begins with endocytosis of the antigen.
2. Once inside the cell, they are enclosed within endosomes that
activate proteases, to degrade the antigen.
3. MHC class II molecules are transported into endocytic
vesicles where they bind peptide antigen, and then travel to the
cell surface.
Antigen Processing and Presentation
General process of antigen processing and presentation
2. Antigen Presentation
 The antigen presented on MHCs is recognised by T
cells using a T cell receptor (TCR). These
are antigen-specific.
 Co-receptors
 As well as the TCR, another T cell molecule is required
for antigen recognition and is known as a co-receptor.
These are either a CD4 or CD8 molecule:
 CD4 is present on T helper cells and only binds to
antigen-MHC II complexes.
 CD8 is present on cytotoxic T cells and only binds to
antigen-MHC I complexes.
Antigen Processing and Presentation
 This therefore leads to very different effects.
1. Antigens presented with MHC II will activate T helper cell.
2. Antigens presented with MHC I activate cytotoxic T cells.
 Cytotoxic T cells will kill the cells that they recognise, whereas T
helper cells have a broader range of effects on the presenting cell such
as:
1. Activation to produce antibodies (in the case of B cells)
2. Activation of macrophages to kill their intracellular pathogens.
MHC-I
MHC-II
MHC lecture.pptx
Antigen Presentation
Antigens are delivered to the surface of APCs by Major
Histocompatibility Complex (MHC) molecules.
Different MHC molecules can bind different peptides. The MHC
is highly polygenic and polymorphic which equips us to
recognise a vast array of different antigens we might
encounter.
There are different classes of MHC, which have different
functions:
MHC class I molecules are found on all nucleated cells (not just
professional APCs) and typically present intracellular antigens
such as viruses.
MHC class II molecules are only found on APCs and typically
present extracellular antigens such as bacteria.
Endogenous Antigens
• Endogenous antigens are proteins found within the
cytosol of human cells. Examples of endogenous
antigens include:
1. Viral proteins produced during viral replication.
2. Proteins produced by intracellular bacteria such as
Rickettsias during their replication.
3. Proteins that have escaped into the cytosol from the
phagosome of phagocytes such as antigen-presenting
cells.
4. Tumor antigens produced by cancer cells.
5. Self-peptides from host cellular proteins.
Endogenous Antigens
ENDOGENOUS PATHWAY
• Endogenous antigens pass through proteasomes where they are
degraded into a series of peptides.
• The peptides are transported into the rough endoplasmic reticulum
(ER) by a transporter protein called TAP.
• The peptides then bind to the grooves of newly synthesized MHC-I
molecules.
• The endoplasmic reticulum transports the MHC-I molecules with
bound peptides to the Golgi complex.
• The Golgi complex, in turn, transports the MHC-I/peptide
complexes by way of an exocytic vesicle to the cytoplasmic
membrane where they become anchored.
• Here, the peptide and MHC-I/peptide complexes can be recognized
by by a complementary-shaped T-cell receptor (TCR) and a CD8
molecule, a co-receptor, on the surface of either a naive T8-
lymphocyte or a cytotoxic T-lymphocyte (CTL).
Endogenous Pathway
Factors required for Endogenous
Pathway
• Proteasomes are complex intracellular proteases that function
in regulated degradation of cellular proteins.
• Calreticulin and calnexin: Type of molecular chaperone
proteins, involved in the assembly of MHC-I and in the
processing of intracellular peptides.
• Transporter associated with antigen processing (TAP):
protein complex belongs to the ATP-binding-cassette
transporter family. essential for peptide delivery from the
cytosol into the lumen of the endoplasmic reticulum (ER),
where these peptides are loaded on major histocompatibility
complex (MHC) I molecules.
• TAP-associated glycoprotein or Tapasin is a critical cofactor.
It promotes the assembly of major histocompatibility complex
(MHC) class I molecules with peptides.
Factors required for Endogenous Pathway
MHC lecture.pptx
A Cytotoxic T-lymphocyte Recognizing a Virus-Infected Cell. Endogenous
antigens are those being produced within the cytosol of the cells of the body.
Examples include proteins from replicating viruses, proteins from intracellular
bacteria, and tumor antigens. The body marks infected cells and tumor cells
for destruction by placing peptide epitopes from these endogenous antigens
on their surface by way of MHC-I molecules. Cytotoxic T-lymphocytes (CTLs)
are then able to recognize peptide/MHC-I complexes by means of their T-cell
receptors (TCRs) and CD8 molecules and kill the cells to which they bind.
EXOGENOUS PATHWAY
 Exogenous antigens, such as viruses, are engulfed and placed in a
phagosome.
 Lysosomes fuse with the phagosome forming an phagolysosome.
 Protein antigens are degraded into a series of peptides.
 MHC-II molecules are synthesized in the endoplasmic reticulum. Within
the endoplasmic reticulum, a protein called the invarient chain (Ii)
attaches to the the peptide-binding groove of the MHC-II molecules and in
this way prevents peptides designated for binding to MHC-I molecules
within the ER from attaching to the MHC-II.
 As the MHC-II molecules with bound Ii chain are transported to the Golgi
complex, the Ii is cleaved, leaving a short peptide called CLIP in the
groove of the MHC molecule.
 The vesicles containing the MHC-II molecules fuse with the peptide-
containing phaglysosomes.
Exogenous Pathway
The CLIP peptide is removed from the MHC-II
molecules and the peptide epitopes are now free
to bind to the grooves of the MHC-II molecules.
The MHC-II molecules with bound peptides are
transported to the cytoplasmic membrane where
they become anchored.
Here, the peptide and MHC-II complexes can be
recognized by T4-lymphocytes by way of TCRs
and CD4 molecules having a complementary
shape.
Exogenous Pathway
MHC lecture.pptx
MHC lecture.pptx
MHC-II molecules with
bound peptides can be
recognized by a
complementary-shaped T-cell
receptor and a CD4 molecule,
a co-receptor, on the surface of
a T4-lymphocyte
T4-lymphocytes are the cells
the body uses to regulate both
humoral immunity and cell-
mediated immunity.
• The invariant chain (Abbreviated Ii) is a
polypeptide which plays a critical role in
antigen presentation. It is involved in the
formation and transport of MHC class II
peptide complexes for the generation of CD4+
T cell responses.
• Class II-associated invariant chain peptide
(CLIP): When Ii undergoes degradation and
leave a peptide fragment (85–101) in length.
MHC lecture.pptx

More Related Content

PPTX
Humoral immune response
PPTX
T CELL RECEPTOR.pptx
PPTX
Antigen processing & presentation
PPTX
Organisation and expression of ig genes
PPTX
T dependent and t independent antigens
PPT
PDF
MHC genes
PPTX
B-cell development.pptx
Humoral immune response
T CELL RECEPTOR.pptx
Antigen processing & presentation
Organisation and expression of ig genes
T dependent and t independent antigens
MHC genes
B-cell development.pptx

What's hot (20)

PPTX
Transcription in eukaryotes
PPT
Antibody diversity
PPTX
Immune response during bacterial, parasitic and viral infection.pptx
PPTX
Reverse Transcription
PPTX
role of sigma factor.pptx
PPT
B cell generation-activation_and_differentiation
PPT
Immunologic memory
PPTX
Post translation modifications(molecular biology)
PDF
Restriction enzymes and their types
PPTX
Tumor immunology
PPTX
B cell differentiation
PPT
transformation
PPTX
Cell mediated immunity (presentation)
PDF
Cot curve, melting temperature, unique and repetitive DNA
PPTX
Major Histocompatibility complex & Antigen Presentation and Processing
PPT
The development of b lymphocytes
PPT
Antigen recognition by t lymphocytes
PPTX
B-cell and humoral immunity
PPTX
Class Switching.pptx
Transcription in eukaryotes
Antibody diversity
Immune response during bacterial, parasitic and viral infection.pptx
Reverse Transcription
role of sigma factor.pptx
B cell generation-activation_and_differentiation
Immunologic memory
Post translation modifications(molecular biology)
Restriction enzymes and their types
Tumor immunology
B cell differentiation
transformation
Cell mediated immunity (presentation)
Cot curve, melting temperature, unique and repetitive DNA
Major Histocompatibility complex & Antigen Presentation and Processing
The development of b lymphocytes
Antigen recognition by t lymphocytes
B-cell and humoral immunity
Class Switching.pptx
Ad

Similar to MHC lecture.pptx (20)

PPTX
Antigen processing and MHC
PPT
Antigen processing lecture-nkn
PPT
Major Histocompatibility Complex
PPTX
Antigen Presentation Pathways.pptx
PPTX
Immunology lectures 6.pptx
PPTX
A Short Note on MHC Molecules
PPTX
MHC I molecules
PPTX
Antigen processing and presentation manu
PPTX
Antigen process and presentation and then MHC Molecules and functions
PPTX
3. MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) 2015.pptx
PDF
Antigen processing and presentation. Antigen – Antibody Interaction.
PDF
Lecture on Antigen processing and presentation pathways
PPTX
MHC.pptx
PPT
Advanced Immunology: Antigen Processing and Presentation
PPTX
Antigen processing and presentation
PDF
31.cellular and hurmonal immunity path.pdf
DOC
12 cellular basis of imune response
PDF
IGNTU-eContent-392458762550-B.Sc-Biotechnology-4-Dr.PrashantKumarSingh-IMMUNO...
PPTX
Cell mediated immunity
DOCX
Antigen processing and MHC
Antigen processing lecture-nkn
Major Histocompatibility Complex
Antigen Presentation Pathways.pptx
Immunology lectures 6.pptx
A Short Note on MHC Molecules
MHC I molecules
Antigen processing and presentation manu
Antigen process and presentation and then MHC Molecules and functions
3. MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) 2015.pptx
Antigen processing and presentation. Antigen – Antibody Interaction.
Lecture on Antigen processing and presentation pathways
MHC.pptx
Advanced Immunology: Antigen Processing and Presentation
Antigen processing and presentation
31.cellular and hurmonal immunity path.pdf
12 cellular basis of imune response
IGNTU-eContent-392458762550-B.Sc-Biotechnology-4-Dr.PrashantKumarSingh-IMMUNO...
Cell mediated immunity
Ad

More from BinteHawah1 (20)

PPTX
T CELL ACTIVATION.pptx
PPTX
immuno-VDJ recombination.pptx
PPTX
hypersensitivity.pptx
PPTX
cytokines presentation 1.pptx
PPTX
B CELL RECEPTOR final.pptx
PPTX
Antibody PPT BTTTT.pptx
PPTX
ADAPTIVE IMMUNITY T CELLS.pptx
PPTX
innate immunity.pptx
PPTX
immunology .pptx
PPTX
immune organs final-1.pptx
PPTX
ENDOCYTOSIS & INFLAMMATION-1.pptx
PPTX
Carbohydrates.pptx
PPTX
zika-virus-disease.pptx
PPTX
vaccines
PPTX
Viral vectors Gene Replacement Therapy.pptx
PDF
Steps_of_Virus_Infections.pdf
PPTX
Replication of Virus.pptx
PPTX
Rabies.E.pptx
PDF
Emerging viruses.pdf
PPTX
Ebola.pptx
T CELL ACTIVATION.pptx
immuno-VDJ recombination.pptx
hypersensitivity.pptx
cytokines presentation 1.pptx
B CELL RECEPTOR final.pptx
Antibody PPT BTTTT.pptx
ADAPTIVE IMMUNITY T CELLS.pptx
innate immunity.pptx
immunology .pptx
immune organs final-1.pptx
ENDOCYTOSIS & INFLAMMATION-1.pptx
Carbohydrates.pptx
zika-virus-disease.pptx
vaccines
Viral vectors Gene Replacement Therapy.pptx
Steps_of_Virus_Infections.pdf
Replication of Virus.pptx
Rabies.E.pptx
Emerging viruses.pdf
Ebola.pptx

Recently uploaded (20)

PDF
شيت_عطا_0000000000000000000000000000.pdf
PDF
Transcultural that can help you someday.
PPTX
ONCOLOGY Principles of Radiotherapy.pptx
PPTX
NASO ALVEOLAR MOULDNIG IN CLEFT LIP AND PALATE PATIENT
PPT
Copy-Histopathology Practical by CMDA ESUTH CHAPTER(0) - Copy.ppt
PDF
focused on the development and application of glycoHILIC, pepHILIC, and comm...
PPTX
the psycho-oncology for psychiatrists pptx
PDF
Intl J Gynecology Obste - 2021 - Melamed - FIGO International Federation o...
PPTX
1. Basic chemist of Biomolecule (1).pptx
PPT
HIV lecture final - student.pptfghjjkkejjhhge
PPTX
antibiotics rational use of antibiotics.pptx
PDF
Extended-Expanded-role-of-Nurses.pdf is a key for student Nurses
PDF
SEMEN PREPARATION TECHNIGUES FOR INTRAUTERINE INSEMINATION.pdf
PDF
Copy of OB - Exam #2 Study Guide. pdf
PPTX
Anatomy and physiology of the digestive system
PPTX
PRESENTACION DE TRAUMA CRANEAL, CAUSAS, CONSEC, ETC.
PPTX
Acute Coronary Syndrome for Cardiology Conference
PPTX
Neuropathic pain.ppt treatment managment
PPTX
Acid Base Disorders educational power point.pptx
PPTX
CHEM421 - Biochemistry (Chapter 1 - Introduction)
شيت_عطا_0000000000000000000000000000.pdf
Transcultural that can help you someday.
ONCOLOGY Principles of Radiotherapy.pptx
NASO ALVEOLAR MOULDNIG IN CLEFT LIP AND PALATE PATIENT
Copy-Histopathology Practical by CMDA ESUTH CHAPTER(0) - Copy.ppt
focused on the development and application of glycoHILIC, pepHILIC, and comm...
the psycho-oncology for psychiatrists pptx
Intl J Gynecology Obste - 2021 - Melamed - FIGO International Federation o...
1. Basic chemist of Biomolecule (1).pptx
HIV lecture final - student.pptfghjjkkejjhhge
antibiotics rational use of antibiotics.pptx
Extended-Expanded-role-of-Nurses.pdf is a key for student Nurses
SEMEN PREPARATION TECHNIGUES FOR INTRAUTERINE INSEMINATION.pdf
Copy of OB - Exam #2 Study Guide. pdf
Anatomy and physiology of the digestive system
PRESENTACION DE TRAUMA CRANEAL, CAUSAS, CONSEC, ETC.
Acute Coronary Syndrome for Cardiology Conference
Neuropathic pain.ppt treatment managment
Acid Base Disorders educational power point.pptx
CHEM421 - Biochemistry (Chapter 1 - Introduction)

MHC lecture.pptx

  • 6. The process by which T cells are screened so that only those capable of binding to MHC are kept alive called positive selection A T cell recognizes antigen as a peptide bound by a particular allelic variant of an MHC molecule, and will not recognize the same peptide bound to other MHC molecules. This behavior of T cells is called MHC restriction The outstanding feature of the MHC molecules is their extensive polymorphism At least three properties of MHC molecules are affected by MHC polymorphism: the range of peptides bound; the conformation of the bound peptide; and the direct interaction of the MHC molecule with the T-cell receptor The interaction between TCRs and peptide-MHC complex is significant in maintaining the immune system against foreign antigens
  • 8. Structure of Class I Molecule
  • 10. Structure of Class II Molecule
  • 12. Difference between MHC I and MHC II
  • 13. 1. Antigen Processing Before an antigen can be presented, it must first be processed. Processing transforms proteins into antigenic peptides.  MHC Class I Molecules 1. Intracellular peptides for MHC class I presentation are made by proteases and the proteasome in the cytosol. 2. Then transported into the endoplasmic reticulum via TAP (Transporter associated with Antigen Processing) to be further processed. 3. They are then assembled together with MHC I molecules and travel to the cell surface ready for presentation. Antigen Processing and Presentation
  • 14.  MCH Class II Molecules 1. The route of processing for exogenous antigens for MHC class II presentation begins with endocytosis of the antigen. 2. Once inside the cell, they are enclosed within endosomes that activate proteases, to degrade the antigen. 3. MHC class II molecules are transported into endocytic vesicles where they bind peptide antigen, and then travel to the cell surface. Antigen Processing and Presentation
  • 15. General process of antigen processing and presentation
  • 16. 2. Antigen Presentation  The antigen presented on MHCs is recognised by T cells using a T cell receptor (TCR). These are antigen-specific.  Co-receptors  As well as the TCR, another T cell molecule is required for antigen recognition and is known as a co-receptor. These are either a CD4 or CD8 molecule:  CD4 is present on T helper cells and only binds to antigen-MHC II complexes.  CD8 is present on cytotoxic T cells and only binds to antigen-MHC I complexes. Antigen Processing and Presentation
  • 17.  This therefore leads to very different effects. 1. Antigens presented with MHC II will activate T helper cell. 2. Antigens presented with MHC I activate cytotoxic T cells.  Cytotoxic T cells will kill the cells that they recognise, whereas T helper cells have a broader range of effects on the presenting cell such as: 1. Activation to produce antibodies (in the case of B cells) 2. Activation of macrophages to kill their intracellular pathogens.
  • 20. Antigen Presentation Antigens are delivered to the surface of APCs by Major Histocompatibility Complex (MHC) molecules. Different MHC molecules can bind different peptides. The MHC is highly polygenic and polymorphic which equips us to recognise a vast array of different antigens we might encounter. There are different classes of MHC, which have different functions: MHC class I molecules are found on all nucleated cells (not just professional APCs) and typically present intracellular antigens such as viruses. MHC class II molecules are only found on APCs and typically present extracellular antigens such as bacteria.
  • 21. Endogenous Antigens • Endogenous antigens are proteins found within the cytosol of human cells. Examples of endogenous antigens include: 1. Viral proteins produced during viral replication. 2. Proteins produced by intracellular bacteria such as Rickettsias during their replication. 3. Proteins that have escaped into the cytosol from the phagosome of phagocytes such as antigen-presenting cells. 4. Tumor antigens produced by cancer cells. 5. Self-peptides from host cellular proteins. Endogenous Antigens
  • 22. ENDOGENOUS PATHWAY • Endogenous antigens pass through proteasomes where they are degraded into a series of peptides. • The peptides are transported into the rough endoplasmic reticulum (ER) by a transporter protein called TAP. • The peptides then bind to the grooves of newly synthesized MHC-I molecules. • The endoplasmic reticulum transports the MHC-I molecules with bound peptides to the Golgi complex. • The Golgi complex, in turn, transports the MHC-I/peptide complexes by way of an exocytic vesicle to the cytoplasmic membrane where they become anchored. • Here, the peptide and MHC-I/peptide complexes can be recognized by by a complementary-shaped T-cell receptor (TCR) and a CD8 molecule, a co-receptor, on the surface of either a naive T8- lymphocyte or a cytotoxic T-lymphocyte (CTL). Endogenous Pathway
  • 23. Factors required for Endogenous Pathway • Proteasomes are complex intracellular proteases that function in regulated degradation of cellular proteins. • Calreticulin and calnexin: Type of molecular chaperone proteins, involved in the assembly of MHC-I and in the processing of intracellular peptides. • Transporter associated with antigen processing (TAP): protein complex belongs to the ATP-binding-cassette transporter family. essential for peptide delivery from the cytosol into the lumen of the endoplasmic reticulum (ER), where these peptides are loaded on major histocompatibility complex (MHC) I molecules. • TAP-associated glycoprotein or Tapasin is a critical cofactor. It promotes the assembly of major histocompatibility complex (MHC) class I molecules with peptides. Factors required for Endogenous Pathway
  • 25. A Cytotoxic T-lymphocyte Recognizing a Virus-Infected Cell. Endogenous antigens are those being produced within the cytosol of the cells of the body. Examples include proteins from replicating viruses, proteins from intracellular bacteria, and tumor antigens. The body marks infected cells and tumor cells for destruction by placing peptide epitopes from these endogenous antigens on their surface by way of MHC-I molecules. Cytotoxic T-lymphocytes (CTLs) are then able to recognize peptide/MHC-I complexes by means of their T-cell receptors (TCRs) and CD8 molecules and kill the cells to which they bind.
  • 26. EXOGENOUS PATHWAY  Exogenous antigens, such as viruses, are engulfed and placed in a phagosome.  Lysosomes fuse with the phagosome forming an phagolysosome.  Protein antigens are degraded into a series of peptides.  MHC-II molecules are synthesized in the endoplasmic reticulum. Within the endoplasmic reticulum, a protein called the invarient chain (Ii) attaches to the the peptide-binding groove of the MHC-II molecules and in this way prevents peptides designated for binding to MHC-I molecules within the ER from attaching to the MHC-II.  As the MHC-II molecules with bound Ii chain are transported to the Golgi complex, the Ii is cleaved, leaving a short peptide called CLIP in the groove of the MHC molecule.  The vesicles containing the MHC-II molecules fuse with the peptide- containing phaglysosomes. Exogenous Pathway
  • 27. The CLIP peptide is removed from the MHC-II molecules and the peptide epitopes are now free to bind to the grooves of the MHC-II molecules. The MHC-II molecules with bound peptides are transported to the cytoplasmic membrane where they become anchored. Here, the peptide and MHC-II complexes can be recognized by T4-lymphocytes by way of TCRs and CD4 molecules having a complementary shape. Exogenous Pathway
  • 30. MHC-II molecules with bound peptides can be recognized by a complementary-shaped T-cell receptor and a CD4 molecule, a co-receptor, on the surface of a T4-lymphocyte T4-lymphocytes are the cells the body uses to regulate both humoral immunity and cell- mediated immunity.
  • 31. • The invariant chain (Abbreviated Ii) is a polypeptide which plays a critical role in antigen presentation. It is involved in the formation and transport of MHC class II peptide complexes for the generation of CD4+ T cell responses. • Class II-associated invariant chain peptide (CLIP): When Ii undergoes degradation and leave a peptide fragment (85–101) in length.